Literature DB >> 32254627

Near-infrared light triggered drug release from mesoporous silica nanoparticles.

Tiancong Zhao1, Liang Chen, Qin Li, Xiaomin Li.   

Abstract

Stimuli triggered drug delivery systems enable controlled release of drugs at the optimal space and time, thus achieving optimal therapeutic effects. As one of the most important stimuli used in bioapplications, near-infrared (NIR) light possesses unique advantages such as deep tissue penetration with minimum auto-fluorescence & tissue scattering and high biosafety. Mesoporous silica nanoparticles (MSNs) are one of the most studied nanocarriers; apart from having a high surface area and large pore volume for loading of drugs, they can be easily functionalized with inorganic nanomaterials and stimuli responsive polymers or organic switch molecules, creating possibilities for designing complex stimuli triggered drug delivery systems. Considering the high tissue penetration depth of NIR light and the unique mesoporous structure of MSNs, NIR responsive inorganic nanoparticle functionalized MSNs can be further combined with stimuli responsive materials to form smart "nano-devices" for controlled drug delivery toward tumors, and to date much progress has been made. In this article, recent advances in the design of NIR triggered mesoporous silica drug delivery systems are systematically summarized and some outstanding studies are highlighted. We will also discuss the shortcomings, challenges and opportunities in the field.

Entities:  

Year:  2018        PMID: 32254627     DOI: 10.1039/c8tb01548a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  9 in total

1.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

2.  Eutectic Gallium-Indium Nanoparticles for Photodynamic Therapy of Pancreatic Cancer.

Authors:  Sabrina S Hafiz; Marvin Xavierselvan; Sumeyra Gokalp; Daniela Labadini; Sebastian Barros; Jeanne Duong; Michelle Foster; Srivalleesha Mallidi
Journal:  ACS Appl Nano Mater       Date:  2022-05-15

3.  Enhanced antitumor activity of carbendazim on HeLa cervical cancer cells by aptamer mediated controlled release.

Authors:  Bilge G Tuna; Pinar B Atalay; Gamze Kuku; E Esma Acar; H Kubra Kara; M Deniz Yilmaz; V Cengiz Ozalp
Journal:  RSC Adv       Date:  2019-11-05       Impact factor: 4.036

4.  pH-Responsive hyperbranched polypeptides based on Schiff bases as drug carriers for reducing toxicity of chemotherapy.

Authors:  Rui Yan; Xinyi Liu; Junjie Xiong; Qiyi Feng; Junhuai Xu; Haibo Wang; Kai Xiao
Journal:  RSC Adv       Date:  2020-04-06       Impact factor: 4.036

5.  Multifunctional Properties of Binary Polyrhodanine Manganese Ferrite Nanohybrids-From the Energy Converters to Biological Activity.

Authors:  Emilia Zachanowicz; Magdalena Kulpa-Greszta; Anna Tomaszewska; Małgorzata Gazińska; Monika Marędziak; Krzysztof Marycz; Robert Pązik
Journal:  Polymers (Basel)       Date:  2020-12-08       Impact factor: 4.329

6.  Construction of a graphene/polypyrrole composite electrode as an electrochemically controlled release system.

Authors:  Mo Zhu; Ying Hao; Xun Ma; Lin Feng; Yuanxin Zhai; Yaping Ding; Guosheng Cheng
Journal:  RSC Adv       Date:  2019-04-23       Impact factor: 3.361

Review 7.  Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform.

Authors:  Fengzhi Cui; Jianhua Liu; Siwen Pang; Bo Li
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 8.  Physically stimulus-responsive nanoparticles for therapy and diagnosis.

Authors:  Fatemeh Farjadian; Soheila Ghasemi; Mohsen Akbarian; Mojtaba Hoseini-Ghahfarokhi; Mohsen Moghoofei; Mohammad Doroudian
Journal:  Front Chem       Date:  2022-09-14       Impact factor: 5.545

Review 9.  Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release.

Authors:  Avelino Corma; Pablo Botella; Eva Rivero-Buceta
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.